A BLOOD test detecting Alzheimer’s years before symptoms show is moving closer, a study suggests.
It follows a breakthrough in identifying chemicals linked to mild cognitive impairment – an early sign of the memory-stealing disease.
And testing for them could lead to patients having drugs or lifestyle changes prescribed early.
The latest discovery is from tests that identified two rogue proteins in the brains of those with mild cognitive impairment.
The proteins show up in plasma, the yellowish liquid that carries blood cells around the body.